About: Rezolute, Inc., a late-stage rare disease company, focuses developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism (HI) in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody which is in Phase 3 clinical trial to treat tumor HI indication, as well as congenital HI. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.93 (-6.43%)
RZLT NASDAQ Rezolute Inc
Rezolute Inc share price
Atividade de preço de RZLT
Último preço
$ 3,930
Variação (24h)
-0,27 USD (6,43%)
Volume
2.27M
Volume (média 4 sem.)
-
Abertura
$ 4,05
Variação do dia
$ 3,86 - $ 4,23
Fechamento anterior
$ 4,20
Último negócio
20 Nov, 9:00 pm GMT+0
Atrasado
20 Nov, 9:00 pm GMT+0
RZLT price performance
Atrasado
20 Nov, 9:00 pm GMT+0
RZLT details
quote.marketSignals